China approves first Covid-19 drug


[09-12-2021 01:19 PM]

Ammon News - China's National Medical Products Administration (NMPA) on Thursday urgently approved a registration request of two antibody Covid-19 drugs for teenagers and adults, making it the first treatment of its kind to get the green light in the country, Jordan News Agency Petra reported.

The antibody cocktail medicine, obtained from isolated antibodies of cured people, was developed by Tsinghua University, Third People's Hospital of Shenzhen and Brii Biosciences (Brii Bio), according to Petra.

The NMPA said the drugs can be used to treat common and mild cases that are at risk of progressing in severity, for people of the age group 12-17.




  • no comments

Notice
All comments are reviewed and posted only if approved.
Ammon News reserves the right to delete any comment at any time, and for any reason, and will not publish any comment containing offense or deviating from the subject at hand, or to include the names of any personalities or to stir up sectarian, sectarian or racial strife, hoping to adhere to a high level of the comments as they express The extent of the progress and culture of Ammon News' visitors, noting that the comments are expressed only by the owners.
name : *
email
show email
comment : *
Verification code : Refresh
write code :